Annual Congress Copenhagen 2005


Material from 2005:
  • 4063 Abstracts
  • 739 Slide presentations
  • 213 Webcasts
  • 93 Handouts
Material from 2005:  Show


Novel therapies for asthma

Poster Discussion
Chairs: M. Molimard (Bordeaux, France), D. Ukena (Bremen, Germany)


Download all media Download all media
 [+]  Congress or journal article abstract 1720 Quality of life of stable dose treatment with salmeterol/fluticasone (SFC) compared with adjustable maintenance dosing (AMD) with formoterol/budesonide (FBC)
D. Price, A. E. Williams, S. Yoxall, A. Gauthier (Aberdeen, Greenford, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1721 R411 treatment reduces asthma exacerbations and attenuates FEV1 fall following steroid withdrawal in moderate asthma
A. D. Rames, W. W. Busse, L. Renzetti, A. S. Nayak (Basel, Switzerland; Madison, Nutley, Peoria, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1722 As-needed treatment with a β2-agonist or a β2-agonist/ corticosteroid combination in mild intermittent asthma (SOMA)
T. Haahtela, K. Tamminen, P. Malmberg, J. Karjalainen, H. Ylä-Outinen, O. Zetterström, T. Ekström, O. Selroos (Helsinki, Finland; , ; Linköping, Sweden)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1723 Ciclesonide decreases exhaled breath nitric oxide and rapidly reduces airway responsiveness to adenosine monophosphate in asthma patients
E. M. Erin, R. Engelstätter, M. Hellwig, T. T. Hansel, P. J. Barnes (London, United Kingdom; Konstanz, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1724 Improving asthma therapy through targeting more effective control of inflammation - a European consensus
S. Holgate, for the European Consensus Conference (Southampton, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1725 Indacaterol: the first once-daily β2-agonist with 24-hour bronchodilation
K. M. Beeh, E. Derom, F. Kanniess, R. Cameron, A. van As (Wiesbaden, Hamburg, Germany; Ghent, Belgium; Horsham, United Kingdom; East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1726 Safety and tolerability of multiple-dose indacaterol, a novel 24-hour β2-agonist, in patients with mild asthma
A. Tarral, N. Fauchoux, H. Knight, S. Perry, J. Wood, L. Brookman (Paris, Rennes, France; , ; Horsham, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1727 Single-dose indacaterol, a novel 24-hour β2-agonist, is well tolerated in patients with mild asthma
T. Duvauchelle, B. Elharrar, H. Knight, A. Krebbs-Brown, S. Perry, P. Freeman, L. Brookman (Paris, France; Basel, Switzerland; Horsham, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1728 Cardiovascular safety of indacaterol, a novel 24-hour β2-agonist, in patients with stable asthma
A. Chuchalin, A. Tsoi, K. Richter, R. Cameron, W. Bao, A. van As (Moscow, Russian Federation; Grosshansdorf, Germany; Horsham, United Kingdom; East Hanover, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1729 Indacaterol, a novel β2-agonist, demonstrates 24-hour efficacy and is well tolerated in patients with asthma: a multiple-dose, dose-ranging study
F. Kanniess, R. Cameron, R. Owen, M. Higgins (Grosshansdorf, Germany; Horsham, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1730 Randomized, placebo-controlled studies of onset and duration of single-dose protection against exercise-induced bronchoconstriction (EIB) by montelukast
G. Philip, J. van Adelsberg, D. S. Pearlman, C. Villaran, T. Loeys, O. Johnson, S. Cupo, T. F. Reiss (Rahway, Denver, United States Of America; Lima, Peru)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1731 A randomised controlled trial of zafirlukast in acute asthma
A. Gulati, S. Kabwa, B. K. Jacob (Colchester, Bradford, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1732 Clinical efficacy of leukotriene antagonist in patients with asthma and allergic rhinitis
T. Koga, H. Matsuse, H. Kohrogi, S. Kohno, H. Aizawa (Kurume, Nagasaki, Kumamoto, Japan)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1733 Montelukast and frequency of exacerbations of asthma
W. A. Biernacki, S. A. Kharitonov, H. M. Biernacka, P. J. Barnes (London, Gravesend, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1734 Comparable efficacy of ciclesonide 160 μg once daily and budesonide 200 μg twice daily in patients with asthma
P. Niphadkar, K. T. Jagannath, S. Hellbardt, R. Engelstätter (Mumbai, Chennai, India; Konstanz, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1735 Ciclesonide 80 μg once daily reduces early and late asthmatic reaction, sputum eosinophils and serum ECP in asthma patients challenged with allergens
G. M. Gauvreau, R. M. Watson, D. S. Postma, J. D. Monchy, F. Deschesnes, L. P. Boulet, A. Widmann, P. M. O‘Byrne (Hamilton, Quebec City, Canada; Groningen, Netherlands; Konstanz, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1736 Ciclesonide 80 μg or 160 μg once daily is comparable to fluticasone propionate 88 μg twice daily in the treatment of asthma patients
H. Magnussen, J. Hofman, B. Novakova, B. Kaczmarek, M. Hellwig, R. Engelstätter (Grosshansdorf, Konstanz, Germany; Bialystok, Lodz, Poland; Trutnov, Czech Republic)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1737 In vitro metabolism of ciclesonide, beclomethasone dipropionate, budesonide and fluticasone propionate in human precision-cut lung slices
R. Nave, R. Fisher, K. Zech (Konstanz, Germany; Tucson, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1738 Low incidence of oropharyngeal adverse events in asthma patients treated with ciclesonide
R. Engelstätter, A. Escher, D. Häfner (Konstanz, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 1739 Uptake, retention and metabolism of ciclesonide in human alveolar epithelial cells
R. Nave, H. Sato, T. Nonaka, T. Mochiduki, S. Takahama, S. Kondo (Konstanz, Germany; Tokyo, Japan)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite